SB 1422 Passes Senate Health Committee 9–2 — Durazo Bill to Restore Medi-Cal for Undocumented Adults Advances to Appropriations
SB 1422 passed the Senate Health Committee 9–2 on April 8, 2026 and was re-referred to Appropriations. The bill would reverse the January 2026 enrollment freeze for undocumented adults aged 19+, directly restoring PPS reimbursement for FQHC visits to this population.
Its fate in Appropriations is uncertain given California's projected $22B deficit by FY2028.
Key takeaways
- Committee passage is meaningful but Appropriations is the real gate — the May 2026 Appropriations hearing is the critical next milestone
- If passed, directly restores PPS revenue for FQHC visits to undocumented adults — critical for LA, Bay Area, and Central Valley FQHCs
Primary source
CalMatters Digital DemocracySource packet
This story's primary source + 4 related tracked stories with theirs — one print-ready digest for your team or board packet.
Free — subscribes you to the weekly Intel Brief. Individual sources are always clickable above, no email needed.
FQHC Talent. (2026, April 8). SB 1422 Passes Senate Health Committee 9–2 — Durazo Bill to Restore Medi-Cal for Undocumented Adults Advances to Appropriations. Primary source: CalMatters Digital Democracy. Retrieved July 28, 2026, from https://www.fqhctalent.com/intel/sb-1422-senate-health-committee-passage-april-2026
More in Legislation
Jul 24
HHS strips disparate-impact liability out of its Title VI regulations — final rule, effective the day it published, no comment period; 45 CFR part 80 binds every Section 330 grantee
Jul 22
Arkansas AG sues 13 drugmakers + a data firm over 340B — the first time a state goes on OFFENSE under its own 340B shield law, with the state health-center association standing beside him
Jul 16
CY2027 Physician Fee Schedule Proposed Rule Lands — CMS Proposes the FQHC PPS Base Rate Rise to $212.91 (+2.5%), Comments Close September 14
Jul 1
8th Circuit Rejects Novartis's Bid to Block Missouri's 340B Contract-Pharmacy Law — Another State Shield Survives a Manufacturer Challenge